🇺🇸 FDA
Patent

US 11124805

Methods, compositions and kits for increasing genome editing efficiency

granted A61PA61P35/00A61P35/02

Quick answer

US patent 11124805 (Methods, compositions and kits for increasing genome editing efficiency) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00